Evolus Statistics
NASDAQ: EOLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.57-0.175 (-2.26%)
Market open · Delayed 15 min · as of Oct 8, 12:02 PM ET
Evolus by the numbers
Evolus has a market capitalization of $499.7 million based on 66.05M shares outstanding. With trailing EPS of $-0.53, Evolus is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.7% below its 50-day average and 22.7% above its 200-day average.
Average daily trading volume is 896.67K shares, or about $6.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EOLS valuation vs. peer median
| Metric | EOLS | Peer median | Difference |
|---|---|---|---|
| Market cap | $499.67M | $500.88M | -0% |
| Avg. volume | 896.67K | 359.98K | +149% |
Peer median across 8 companies: ACRS, MPLT, CBIO, OCS, BLSM, PBYI, ALT, DRUG.
Valuation
- Market cap
- $499.67M
- Forward P/E
- 25.86
- EPS (TTM)
- $-0.53
- Shares outstanding
- 66.05M
Price and trading
- Previous close
- 7.74
- Open
- 7.68
- Day range
- 7.55 – 7.68
- 52-week range
- 3.86 – 9.31
- 52-week change
- +23.64%
- Beta
- —
- Volume
- 276.08K
- Average volume
- 896.67K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 499.67M
- Forward Pe
- 25.86
- Eps
- -0.53
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.31
- Week52 Low
- 3.86
- Avg Volume
- 896.67K
- Shares Outstanding
- 66.05M
- Ma50
- 7.94
- Ma200
- 6.16
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -18.74%
- Pct From52w Low
- 95.98%